$MDCO has been having a banner year with the stock up over 200%. We think this rally still has legs and that $MDCO is going to keep climbing after Monday's huge breakout. Here's a look at what drove Monday's breakout. Results from a Phase 3 clinical trial, ORION-9, evaluating the effect of The Medicines Company's (MDCO +2.3%) inclisiran on reducing "bad"...
Bullish Ascending Price Channel had formed from December 2018 until it finally broke out in early September. The price consolidated for a bit before rising further. I am expecting a pullback that could retest the previous resistance line of the price channel around the $50 level.
MDCO just breaking down some long term support. We think it has good downside potential if it breaks below $37.33 * Trade Criteria * Date First Found- June 15, 2017 Pattern/Why- Long term support breakdown short Entry Target Criteria- Break of $37.33 Exit Target Criteria- 1st target $34.33 Stop Loss Criteria- $39.33 Please check back for Trade updates....
Upward channel break down in longer frame & formed a pennant now. Money-flow is moving down. We think it will decline around 30 You can check our detailed analysis on MDCO in the trading room/ Executive summery link here- www.screencast.com Time Span: 33:00” Trade Suggestion Date: 5th Jul Trade status: waiting for entry confirmation